Assessment of Impact of Peptide Nucleic Acid Fluorescence In Situ Hybridization for Rapid Identification of Coagulase-Negative Staphylococci in the Absence of Antimicrobial Stewardship Intervention

被引:77
作者
Holtzman, Carol [1 ]
Whitney, Dana [1 ]
Barlam, Tamar [2 ,3 ]
Miller, Nancy S. [3 ,4 ]
机构
[1] Boston Med Ctr, Dept Pharm, Boston, MA USA
[2] Boston Med Ctr, Infect Dis Sect, Dept Med, Boston, MA USA
[3] Boston Univ, Sch Med, Boston, MA 02118 USA
[4] Boston Med Ctr, Dept Pathol & Lab Med, Boston, MA USA
关键词
THERAPY;
D O I
10.1128/JCM.02461-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Peptide nucleic acid fluorescence in situ hybridization (PNA FISH) was instituted at Boston Medical Center for the rapid identification of coagulase-negative staphylococci (CoNS). Without active notification or antimicrobial stewardship intervention, a pre- and postimpact analysis showed no benefit of this assay with respect to the length of hospital stay or vancomycin use.
引用
收藏
页码:1581 / 1582
页数:2
相关论文
共 4 条
[1]   Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs [J].
Forrest, G. N. ;
Mankes, K. ;
Jabra-Rizk, M. A. ;
Weekes, E. ;
Johnson, J. K. ;
Lincalis, D. P. ;
Venezia, R. A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) :3381-3383
[2]   Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: Delivering earlier effective antimicrobial therapy [J].
Forrest, Graeme N. ;
Roghmann, Mary-Claire ;
Toombs, Latoya S. ;
Johnson, Jennifer K. ;
Weekes, Elizabeth ;
Lincalis, Durry P. ;
Venezia, Richard A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) :3558-3563
[3]   Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures [J].
Forrest, Graerne N. ;
Mehta, Sanjay ;
Weekes, Elizabeth ;
Lincalis, Durry P. ;
Johnson, Jennifer K. ;
Venezia, Richard A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) :154-158
[4]  
Ly Tam, 2008, Ther Clin Risk Manag, V4, P637